Inmed Pharmaceuticals INC. (INM) — 10-K Filings
All 10-K filings from Inmed Pharmaceuticals INC.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
InMed Pharma Pushes Pipeline Amidst Funding Needs
— Sep 23, 2025 Risk: high
InMed Pharmaceuticals Inc. (INM) reported a market value of voting and non-voting common equity held by non-affiliates of $3,316,582 as of December 31, 2024, wi -
InMed Pharmaceuticals Inc. Files 2024 Annual Report
— Sep 30, 2024 Risk: medium
InMed Pharmaceuticals Inc. filed its annual report for the fiscal year ended June 30, 2024. The company, incorporated in British Columbia, Canada, operates in t
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX